SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is under pressure after Chinese memory maker CXMT outlined a denser DRAM design for DDR5 server memory, raising concerns about future competition and memory pricing. Traders disagree on whether the development is a meaningful threat or an overreaction, noting uncertainty around CXMTs ability to scale while pointing to ongoing AI-driven memory demand.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intels sharp decline is being discussed alongside a broader semiconductor selloff, with traders citing concerns about AI-infrastructure funding and returns, Chinese memory competition, and uncertainty over Intels foundry prospects. Some see the pullback as oversold and buyable, while others are frustrated by the lack of confirmed foundry wins and fear further downside.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

Sharp swings in South Korean equities are driving attention to KORU, whose 3x leverage amplifies moves in the KOSPI, particularly in chip-heavy holdings Samsung and SK Hynix; traders point to volatile memory and AI-chip sentiment and leveraged-position unwinds. The community is split between buying for a rebound on continued AI-memory demand and warning that further selling and leverage-related volatility could deepen losses.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealths upcoming quarterly earnings are the main focus, with traders watching medical-cost trends, the medical care ratio and guidance for signs that its recovery is holding. Sentiment is sharply divided between hopes for a beat and raised outlook and fears that persistent cost pressures could trigger a selloff.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFis steep selloff toward its 52-week lows is driving discussion, with traders pointing to a bearish analyst downgrade and concerns about high rates, valuation and the upcoming earnings outlook. Bulls argue the decline is driven by short sellers or market pressure and cite continued business growth, while bears see further downside risk.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is under pressure as semiconductor and memory-chip stocks sell off, with traders citing fears that China could expand AI-memory production and pointing to weakness in Korean chip shares, Micron and SanDisk. Some see the decline as an overreaction and expect a bounce, while others warn that selling momentum remains strong and further losses are possible.

Wachovia Corporation, a financial holding company, provides commercial and retail banking services, and other financial services. Wachovia was a diversified financial services company based in Charlotte, North Carolina. Before its acquisition by Wells Fargo in 2008, Wachovia was the fourth-largest bank holding company in the United States based on total assets. Wachovia provided a broad range of banking, asset management, wealth management, and corporate and investment banking products and services. At its height, it was one of the largest providers of financial services in the United States, operating financial centers in 21 states and Washington, D.C., with locations from Connecticut to Florida and west to California.

Wells Fargo & Co.

Wells Fargos upcoming third-quarter earnings report is the main focus, with traders watching net interest income, credit quality and consumer trends as major banks begin reporting. Sentiment is split between hopes for strong results and a rebound, and concerns that bank weakness or disappointing guidance could weigh on the shares.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies Inc

Rocket shares are under pressure near a 52-week low as high mortgage rates weigh on housing and lending demand, alongside analyst price-target cuts. Traders are split between expecting further downside and viewing the selloff as an opportunity, with bulls pointing to Rockets servicing business and potential upside if rates ease.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is under pressure in a broad memory-chip selloff, with traders pointing to Chinese maker CXMTs progress on a denser DRAM design and fears that rising supply or weaker AI infrastructure spending could undermine the memory-cycle outlook. Bears see further downside from competition and valuations, while bulls argue the news targets DRAM rather than SanDisks NAND business and view the decline as an overreaction or buying opportunity.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturuss OTC deficiency Phase 2 update, LUNAR 2.0 platform unveiling and myNEO acquisition are driving discussion. Traders see promise in the reported trial findings and expanded platform, while others view the switch to ARCT-2601, delayed timelines and added spending as a disappointing near-term trade-off.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS It&#39;s to be expected with increasing share price before REGAL FA readout and SLS-009 catalysts, but it&#39;s real shame there are these traders throwing price targets like this. 
 
Do whatever you want with your trades but don&#39;t make comments like this throwing out $6/$7 targets. 
 
There are 99.99% chances of REGAL success, and you can read through all the DD that provides this statistically accurate prediction.  Failure is a statistical impossibility. 
 
And if you&#39;ve looked at the DD and don&#39;t understand that, you&#39;re intentionally being ignorant, ignoring what is clear as day. 
 
Real upside from $5.50 a share is 5X to 29X.  I encourage everyone to hold through REGAL FA and buyout, as the strategic acquisition will be gigantic. 
 
Do whatever you want with your trades but don&#39;t try to downplay the upside.  And stop comparing SLS to any other biotech, it&#39;s an ignorant comparison.  This isn&#39;t &quot;binary,&quot; it&#39;s deep value given the margin of safety in the trial. 
 
Fortunes will be made with sizeable positions.

Slippin Jimmy RETURNS

Enrico Papke

Geukinas

🤠

YEHMINGZHU

Louise

Dr. Arogart

Federico

Mark Hansen

Stocktwits

Ehrenhardt

Emagen

Paulstoxk

Bennyterner

Duncan Teo

Alan

Webbie

Easy E

Dave

Paul Fields

Khari Knapp

F. S. Fetchet

mrittika1971

Spaceyboy

Chessdoc

John

johnychicago

Patrick

$SLS  For those that didn&#39;t realize, my question was sincere as I&#39;ve been a strong supporter of $SLS for over 2 years.  Bullish on every post...and get attacked for asking a simple question.   
 
Thanks for those that were cordial and shared their DD (regardless of side, they are all data points so thank you). 
 
For the $SLS &quot;can&#39;t miss&quot; bro pumpers, take a lesson from $ALT.   
 
For the $ALT low life&#39;s attacking any post I make because I exposed $ALT, thanks to continue to show I live rent free in your head.  
 
My first $SLS post - March 1, 2024...Bullish

StockTwits Web

SELLAS Life Sciences Group Inc

Altimmune Inc

The Legendary Mayor

 It's to be expected with increasing share price before REGAL FA readout and SLS-009 catalysts, but it's real shame there are these traders throwing price targets like this. 
 
Do whatever you want with your trades but don't make comments like this throwing out $6/$7 targets. 
 
There are 99.99% chances of REGAL success, and you can read through all the DD that provides this statistically accurate prediction.  Failure is a statistical impossibility. 
 
And if you've looked at the DD and don't understand that, you're intentionally being ignorant, ignoring what is clear as day. 
 
Real upside from $5.50 a share is 5X to 29X.  I encourage everyone to hold through REGAL FA and buyout, as the strategic acquisition will be gigantic. 
 
Do whatever you want with your trades but don't try to downplay the upside.  And stop comparing SLS to any other biotech, it's an ignorant comparison.  This isn't "binary," it's deep value given the margin of safety in the trial. 
 
Fortunes will be made with sizeable positions.

@yG19 most here know this penny flip, flips and flops like fish washed up and in with the shore….

Herda Christian

Roger Rabbit $5,56

Robert

 most here know this penny flip, flips and flops like fish washed up and in with the shore….

5,500% ROI this quarter

@yG19 BioRich is strange... almost pathological, if you read through all his posts. How can he waste his time badmouthing something like ALT!? He probably just wants attention to promote VERU! Good luck with that!

 BioRich is strange... almost pathological, if you read through all his posts. How can he waste his time badmouthing something like ALT!? He probably just wants attention to promote VERU! Good luck with that!

@yG19 Greetings.  I think you misread my post.  It was from 2 years ago and referenced the analyst PTs.  As you&#39;ll see on that post, $SLS was under a buck.  No PTs made then and no PTs made now.   
 
As for the 99.99% chance and your eager optimism, it&#39;s a flag.  Caused me to look.  You are posting solely to $SLS and have no Watchlist.  Not sure how good you are, but that&#39;s a flag as well.  Combined, they are a red flag.  
 
As for comparison to other bios, I was only referring the scammish vibe that was felt on the ALT board.  That&#39;s all.  Not even the same sectors.  But, unfortunately, your post supports the scammish vibe on $SLS.

Paul Nipkow

 Greetings.  I think you misread my post.  It was from 2 years ago and referenced the analyst PTs.  As you'll see on that post, 

 was under a buck.  No PTs made then and no PTs made now.   
 
As for the 99.99% chance and your eager optimism, it's a flag.  Caused me to look.  You are posting solely to 

 and have no Watchlist.  Not sure how good you are, but that's a flag as well.  Combined, they are a red flag.  
 
As for comparison to other bios, I was only referring the scammish vibe that was felt on the ALT board.  That's all.  Not even the same sectors.  But, unfortunately, your post supports the scammish vibe on 

@yG19 mute this guy… he is a hired hack for shorts.  He blindly bashes with no DD.
Don’t waste an ounce of energy or thought to this guy
He is a looser

StockTwits for iOS

 mute this guy… he is a hired hack for shorts.  He blindly bashes with no DD.
Don’t waste an ounce of energy or thought to this guy
He is a looser

Ricko4

@yG19 IG19, excellent DD as always. I’ve had @Biorich blocked for ages because he’s a toxic joke, so I’m replying here in your thread. 🚫
It’s pathetic how this &#39;Dean&#39; copy-pasted your hard work and 99.9% stats just to act smart while calling $ALT investors &#39;low lives.&#39; Anyone with a brain knows Pemvidutide is a masterpiece molecule for liver health and muscle mass—something his parrot-brain clearly can&#39;t grasp. He’s a hypocritical gasbag who does zero original research and lives off your credit. Absolute loser. Real investors see right through his &#39;national sport&#39; of bashing value. Keep up the great work, IG

 IG19, excellent DD as always. I’ve had 

 blocked for ages because he’s a toxic joke, so I’m replying here in your thread. 🚫
It’s pathetic how this 'Dean' copy-pasted your hard work and 99.9% stats just to act smart while calling 

 investors 'low lives.' Anyone with a brain knows Pemvidutide is a masterpiece molecule for liver health and muscle mass—something his parrot-brain clearly can't grasp. He’s a hypocritical gasbag who does zero original research and lives off your credit. Absolute loser. Real investors see right through his 'national sport' of bashing value. Keep up the great work, IG